33 related articles for article (PubMed ID: 2141506)
1. A novel bioluminescent protease assay using engineered firefly luciferase.
Wigdal SS; Anderson JL; Vidugiris GJ; Shultz J; Wood KV; Fan F
Curr Chem Genomics; 2008 Oct; 2():16-28. PubMed ID: 20161840
[TBL] [Abstract][Full Text] [Related]
2. Angiogenesis: possibilities for therapeutic interventions.
Wynendaele W; van Oosterom AT; Pawinski A; de Bruijn EA; Maes RA
Pharm World Sci; 1998 Dec; 20(6):225-35. PubMed ID: 9972522
[TBL] [Abstract][Full Text] [Related]
3. Cell-signaling targets for antitumour drug development.
Brunton VG; Workman P
Cancer Chemother Pharmacol; 1993; 32(1):1-19. PubMed ID: 8384936
[No Abstract] [Full Text] [Related]
4. The inhibitory effect caused by suramin on the paracrine growth of human cancer cells and fibroblasts.
Mukaida H; Hirabayashi N; Hirai T; Yamashita Y; Iwata T; Saeki S; Toge T
Surg Today; 1994; 24(3):234-40. PubMed ID: 8003867
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of growth factor binding, Ca2+ signaling and cell growth by polysulfonated azo dyes related to the antitumor agent suramin.
Powis G; Seewald MJ; Melder D; Hoke M; Gratas C; Christensen TA; Chapman DE
Cancer Chemother Pharmacol; 1992; 31(3):223-8. PubMed ID: 1464160
[TBL] [Abstract][Full Text] [Related]
6. Clinical trials with anticoagulant and antiplatelet therapies.
Zacharski LR; Meehan KR; Algarra SM; Calvo FA
Cancer Metastasis Rev; 1992 Nov; 11(3-4):421-31. PubMed ID: 1423826
[TBL] [Abstract][Full Text] [Related]
7. Suramin is an inhibitor of DNA topoisomerase II in vitro and in Chinese hamster fibrosarcoma cells.
Bojanowski K; Lelievre S; Markovits J; Couprie J; Jacquemin-Sablon A; Larsen AK
Proc Natl Acad Sci U S A; 1992 Apr; 89(7):3025-9. PubMed ID: 1313577
[TBL] [Abstract][Full Text] [Related]
8. Suramin.
Eisenberger MA; Reyno LM
Cancer Treat Rev; 1994 Jul; 20(3):259-73. PubMed ID: 8020006
[No Abstract] [Full Text] [Related]
9. Other chemotherapy regimens including mitoxantrone and suramin.
Siu LL; Moore MJ
Semin Urol Oncol; 1997 Feb; 15(1):20-7. PubMed ID: 9050136
[TBL] [Abstract][Full Text] [Related]
10. Suramin for prostatic cancer: a phase I/II study in advanced extensively pretreated disease.
Van Oosterom AT; De Smedt EA; Denis LJ; de Bruijn EA; Mahler C
Eur J Cancer; 1990 Apr; 26(4):422. PubMed ID: 2141506
[No Abstract] [Full Text] [Related]
11. Suramin for breast and prostate cancer: a pilot study of intermittent short infusions without adaptive control.
Woll PJ; Ranson M; Margison J; Thomson Y; van der Water L; George N; Howell A
Ann Oncol; 1994 Sep; 5(7):597-600. PubMed ID: 7993834
[TBL] [Abstract][Full Text] [Related]
12. Suramin and hydrocortisone: determining drug efficacy in androgen-independent prostate cancer.
Kelly WK; Scher HI; Mazumdar M; Pfister D; Curley T; Leibertz C; Cohen L; Vlamis V; Dnistrian A; Schwartz M
J Clin Oncol; 1995 Sep; 13(9):2214-22. PubMed ID: 7666079
[TBL] [Abstract][Full Text] [Related]
13. Phase I study of suramin given by intermittent infusion without adaptive control in patients with advanced cancer.
Kobayashi K; Vokes EE; Vogelzang NJ; Janish L; Soliven B; Ratain MJ
J Clin Oncol; 1995 Sep; 13(9):2196-207. PubMed ID: 7666078
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a pharmacokinetically based fixed dosing scheme for suramin.
Reyno LM; Egorin MJ; Eisenberger MA; Sinibaldi VJ; Zuhowski EG; Sridhara R
J Clin Oncol; 1995 Sep; 13(9):2187-95. PubMed ID: 7666077
[TBL] [Abstract][Full Text] [Related]
15. Phase I and clinical evaluation of a pharmacologically guided regimen of suramin in patients with hormone-refractory prostate cancer.
Eisenberger MA; Sinibaldi VJ; Reyno LM; Sridhara R; Jodrell DI; Zuhowski EG; Tkaczuk KH; Lowitt MH; Hemady RK; Jacobs SC
J Clin Oncol; 1995 Sep; 13(9):2174-86. PubMed ID: 7666076
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]